Maxim Group Initiates Coverage On HeartBeam with Buy Rating, Announces Price Target of $2

HeartBeam

HeartBeam

BEAT

0.00

Maxim Group analyst Anthony Vendetti initiates coverage on HeartBeam (NASDAQ: BEAT) with a Buy rating and announces Price Target of $2.